Produkty 1329805-78-8

CAS 1329805-78-8 to numer rejestracyjny substancji (6Ar,10aR)-6,6,9-trimethyl-3-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)-6a,7,10,10a-tetrahydrobenzo(c)chromen-1-ol. Oferty producentów: Biosynth. Dostępne opakowania: 5mg, 1mg, 10mg, 25mg, 50mg.

(6Ar,10aR)-6,6,9-trimethyl-3-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)-6a,7,10,10a-tetrahydrobenzo(c)chromen-1-ol
Biosynth
  • opakowanie: 5mg, 1mg, 10mg, 25mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(6aR,10aR)-6,6,9-trimethyl-3-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (CAS 1329805-78-8) to związek chemiczny o wzorze sumarycznym C21H30O2 i masie molowej 323.5 g/mol. Nazwa systematyczna IUPAC: (6aR,10aR)-6,6,9-trimethyl-3-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol. InChIKey: HCAWPGARWVBULJ-OGIBJJSFSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O2
Masa molowa323.5 g/mol
Nazwa IUPAC(6aR,10aR)-6,6,9-trimethyl-3-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
InChIKeyHCAWPGARWVBULJ-OGIBJJSFSA-N
SMILES[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Delta8-THC-d9, 6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol-d9, 8-Tetrahydro Cannabinol-d9, .delta.8-THC-d9, Delta8-Tetrahydrocannabinol-d9, (+/-)-delta8-Tetrahydrocannabinol-d9
Powiązane formy tego związku
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
Izomery (ten sam wzór sumaryczny)
1-[(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H30O2
methyl (1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate C21H30O2
[(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C21H30O2
(8R,9S,13S,14S,17S)-13-methyl-3-propoxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-ol C21H30O2
4-[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]benzene-1,2-diol C21H30O2
(8S,9R,10S,13S,14S,17S)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C21H30O2
(6aR,10aS)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol C21H30O2
(8S,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O2
[(3S,8S,9S,10R,14S)-10,17-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O2
(8S,9R,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C21H30O2